1 results match your criteria: "Cardiology and Angiology Justus-Liebig-University Giessen Germany.[Affiliation]"
CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy.
Pulm Circ
January 2022
Department of Internal Medicine I, Cardiology and Angiology Justus-Liebig-University Giessen Germany.
Article Synopsis
- The study assessed CILP1 levels in 98 patients with ischemic cardiomyopathy (ICM) versus 30 controls, finding higher CILP1 concentrations in ICM patients.
- CILP1 levels in ICM correlated with lower right ventricular ejection fraction (RVEF) and higher right ventricular end-systolic volume index, but not with left ventricular parameters.
- CILP1 showed potential as a significant biomarker for predicting RVEF < 40% in ICM, with comparable efficacy to NT-proBNP, highlighting its relevance in assessing right ventricular dysfunction.